American Brain Foundation notes that the World Health Organization released updated guidelines on reducing the risk of dementia and cognitive decline, noting that 45% of dementia risk can be attributed to modifiable factors.
Public source
Publisher name
Public post
Finding ways to treat and stop the progression of dementia are top priorities for research, but the best defense is preventing it from developing in the first place. Las…
Company
American Brain Foundation
We bring researchers and donors together to cure brain diseases and disorders.
- Industry
- Fundraising
- Location
- Minneapolis, US
- Company size
- 11–50 employees
About American Brain Foundation
Since 1992, the American Brain Foundation has been investing in research to end the battle against brain diseases and disorders. We are a national foundation in relentless pursuit to identify causes, improve treatments, and discover cures. We unite donors and researchers to impact patient lives and those around them. We invest in research of the whole brain and all nervous system disorders knowing they are interconnected. This holistic, innovative approach allows us to build bridges between diseases and break new ground in research and application. Believing in a whole-brain approach gives us an edge in understanding and combating brain disease. We understand that when we cure one of them, we will cure many. Learn more by visiting www.AmericanBrainFoundation.org. Mission: The American Brain Foundation brings researchers and donors together to cure brain diseases and disorders. Vision: Life without brain disease.
See moreLatest activity
Latest activity from American Brain Foundation
7 signals
Presence & Recognition
American Brain Foundation honored the cast and writers of Apple TV's Shrinking series with the 2026 Advocate Award at the American Brain Foundation Gala in Nashville on September 12.
Products & Services
American Brain Foundation updated its Brain Diseases from A–Z webpage to add information about Charcot-Marie-Tooth Disease, including symptoms, diagnosis, and research.
Research & Knowledge
American Brain Foundation awarded a Next Generation Research Grant to Amy Waldman, MD, who led studies culminating in the FDA approval of the first-ever treatment for Alexander disease, Zanvastro (zilganersen), administered via spinal injection.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Alzheimer's Disease International
Alzheimer's Disease International is entering a new era in dementia innovation with new diagnostic tools and emerging treatments in 192 trials.
Research & Knowledge
Alzheimer's Disease Data Initiative
Alzheimer's Disease Data Initiative released data from the ALFA+ longitudinal study available to researchers via AD Workbench.
Research & Knowledge
BrightFocus Foundation
BrightFocus Foundation's Alzheimer's Disease Research program supported Dr. Ksenia Kastanenka of Mass General Brigham investigating disrupted sleep and its contribution to Alzheimer's progression and treatment.
Research & Knowledge
Alzheimer's Society
Alzheimer's Society is calling for a bold and ambitious plan for earlier diagnosis to unlock a clear path forward for people living with dementia and their families.
Partnerships
Alzheimer's Drug Discovery Foundation